EMA has released the second module of a new guideline on influenza vaccines for a six-month public consultation. The guidance covers the non-clinical and clinical requirements for the development of new influenza vaccines and aims to facilitate the prompt assessment of new vaccines. It follows the publication of a module on the quality requirements.

Catalent?s $870 million IPO will help company reduce debt, enable future growth.

The latest revisions to the USP General Chapters <41> Balances and <1251> Weighing on an Analytical Balance aim to ensure weighing accuracy and eliminate unnecessary overtesting by simplifying previous descriptions and reflecting current state-of-the-art weighing practices.

Hovione announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by FDA.

A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.

Pharmaceutical Technology Europe Marks 25 years of drug-development advances.

Pfizer announced an agreement to acquire Baxter International?s marketed vaccines for $635 million.

FDA issues a warning letter to Zhejiang Jiuzhou Pharmaceutical Co., Ltd. and its import/export company for multiple CGMP violations and misbranded products.

Croda, an excipients supplier, announced that it has obtained EXCiPACT certification for its excipients manufacturing site at Mevisa, Spain.

SGS to add testing laboratories for biotechnology, extractables and leachables, and elemental impurities to Shanghai facility.

The regulatory filing marks the first step in the approval process toward making RTS,S available as an addition to existing tools currently recommended for malaria prevention.

Packaging Coordinators, Inc. expands its services with acquisition of Penn Pharmaceutical Services.

Former healthcare association executive selected to lead International Society for Pharmaceutical Engineering.

Study provides first substantive reference data on key quality attributes of empty capsules

Hospira recalls one lot of Lidocaine HCI Injection, USP, 2%, 20 mg per mL single-dose vial, preservative-free, due to particulate matter.

The president and CEO of Southern Research Institute has been named president of the Controlled Release Society.

PrimePac tubes, part of the company's new portfolio of packaging, have been specifically designed with a safety zone to hold tablet punches in position to stop damage to the tip face.

Bristol-Myers Squibb and Ono Pharmaceutical will jointly develop and commercialize immuno-oncology drugs for Japan, South Korea, and Taiwan.

European Pharmacopoeia Commission validated its strategy regarding elemental impurities and the implementation plan of the upcoming ICH Q3D guideline.

Sandoz is first to file for FDA approval of a biologic under the biosimilars pathway created in the Biologics Price Competition and Innovation Act of 2009.

CPI invests $34 million to develop a Biologics Factory of the Future due to open in 2017.

Novasep gains approval from FDA to produce new molecular entity for US market.

MedImmune and Advaxis partner on immuno-oncology combination clinical trial.

American Health Packaging announced a voluntary nationwide recall of ibuprofen and oxcarbazepine tablets due to mislabeling on the inner unit dose blister packaging.

Unique Pharmaceuticals has issued a voluntary recall of sterile compounded preparations, but aired concerns about FDA?s recall demand.

AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.

AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.

CPhI 2014 panel additions to provide global insights from the contract services sector.